2 Patents
- US119393612024Compositions of Peptide Inhibitors of Interleukin-23 Receptor
Protagonist Therapeutics, Inc.
0 cites - US118847482024Oral Peptide Inhibitors of Interleukin-23 Receptor and Their Use to Treat Inflammatory Bowel Diseases
Protagonist Therapeutics, Inc.
0 cites